35 drugmakers to produce generic version of Paxlovid

The Medicines Patent Pool signed agreements March 17 with 35 generic drugmakers to manufacture Paxlovid, Pfizer’s COVID-19 antiviral pill, to advance the drug’s accessibility in 95 developing countries.